Trials / Completed
CompletedNCT06960148
Dentinal Hypersensitivity Reduction Efficacy Study
Clinical Investigation of the Dentinal Hypersensitivity Reduction Efficacy of CSPR Toothpaste Containing 8% Arginine Compared to Colgate Cavity Protection Toothpaste Immediately Following Direct Topical Application of the Product and After Subsequent Brushing With the Product for Eight Weeks.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- Colgate Palmolive · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Assess the clinical efficacy of CSPR Toothpaste containing 8% arginine to provide dentinal hypersensitivity relief
Detailed description
The objective of this study is to assess the clinical efficacy of CSPR Toothpaste containing 8% arginine to provide dentinal hypersensitivity relief (tactile and air blast) at instant, 3 days, 4 weeks and 8 weeks in comparison to Colgate Cavity Protection Toothpaste over an eight-week period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CSPR Toothpaste | a commercially available 8% arginine toothpaste |
| DRUG | Colgate Dental Cream Toothpaste | a commercially available fluoride toothpaste |
Timeline
- Start date
- 2025-03-04
- Primary completion
- 2025-05-13
- Completion
- 2025-05-13
- First posted
- 2025-05-07
- Last updated
- 2026-03-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06960148. Inclusion in this directory is not an endorsement.